18:2818:28, 13 April 2023diffhist+9
Ranolazine
7 hrs apparent half life of MR preparation. Less for drug - https://pubmed.ncbi.nlm.nih.gov/16640453/#:~:text=Elimination%20half%2Dlife%20of%20ranolazine,(flip%2Dflop%20kinetics).
10:5110:51, 23 May 2022diffhist−123
Sodium butyrate
Alleged effect of legumes longevity is trivia unrelated to the chemical, unless well evidenced that it is the chemical that has this effect not the legumes/lifestyle.
18 October 2021
11:3811:38, 18 October 2021diffhist+36
Remifentanil
→Potency: First reference looks at analgesia-sedation i.e., the sedation score, not analgesia, and is a single small trial so on this weak evidence we probably shouldn't state it as a fact that remifentanil is superior
12:3612:36, 27 March 2021diffhist+118
Extended-release morphine
→Structure: Unable to confirm source for claims of plastic spheroids with pH dependent pores. UK manufacturer's datasheets do not detail spheroids' presence in faeces in contrast to what is normal for similar formulations (Episenta, Asacol etc) Personal communication with Ethylpharm - UK manufacturer of Zomorph MR morphine brand was fruitless.
22 March 2021
11:4911:49, 22 March 2021diffhist+22
Metronidazole
Implying that it it may not be considered safe in breastfeeding misrepresents the consensus and cause undue worry.
16:1916:19, 6 September 2019diffhist+43
Metronidazole
Metronidazole benzoate hydrolysed in GI tract rather then stomach, and unsuitability in feeding tubes is unsupported by primary evidence and unreferenced by authors speculating it to be the case.
14:5314:53, 2 September 2019diffhist+120
Metronidazole
→Medical uses: Paper reference 13 does not provide a source for the claim that metronidazole benzoate requires hydrolysis in the stomach for efficacy and in personal communication the authors were unable to provide a source. I suspect it is long-running folk-wisdom; without evidence it should not be asserted as fact.
10:3610:36, 18 December 2018diffhist+78
Nitrofurantoin
This uncommon reaction may occur 1 month to 6 years after starting the drug and is usually related to its total lifetime dose.{{Citation needed|reason= source for lifetinme dose claim|date=December 2018}}
12 November 2018
10:3110:31, 12 November 2018diffhist−314
Aminolevulinic acid
→Activation of mitochondria: thereby increasing glucose consumption and it helps in addressing the problem of low energy levels of patients.<ref>Bratic, I., Trifunovic, A. (2010). Mitochondrial energy and ageing. Biochimica et Biophysica Acta-Bioenergetics, 1797,961-967.</ref>" deletd comment as claim is not supported by the referencece provided. "Energy levels" is a nonsense term and smacks or quackery and vested interest.
8 November 2018
17:1617:16, 8 November 2018diffhist−20
Medical cannabis
Whole-plant cannabis for medicinal use is not legal in the UK. The recent legal changes allow for cannabis-based medicinal products. See https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/753172/Factsheet_-_Cannabis_CBD_and_Cannabinoids_-_v_1_2__2018.pdf
18:2818:28, 13 April 2023diffhist+9
Ranolazine
7 hrs apparent half life of MR preparation. Less for drug - https://pubmed.ncbi.nlm.nih.gov/16640453/#:~:text=Elimination%20half%2Dlife%20of%20ranolazine,(flip%2Dflop%20kinetics).
10:5110:51, 23 May 2022diffhist−123
Sodium butyrate
Alleged effect of legumes longevity is trivia unrelated to the chemical, unless well evidenced that it is the chemical that has this effect not the legumes/lifestyle.
18 October 2021
11:3811:38, 18 October 2021diffhist+36
Remifentanil
→Potency: First reference looks at analgesia-sedation i.e., the sedation score, not analgesia, and is a single small trial so on this weak evidence we probably shouldn't state it as a fact that remifentanil is superior
12:3612:36, 27 March 2021diffhist+118
Extended-release morphine
→Structure: Unable to confirm source for claims of plastic spheroids with pH dependent pores. UK manufacturer's datasheets do not detail spheroids' presence in faeces in contrast to what is normal for similar formulations (Episenta, Asacol etc) Personal communication with Ethylpharm - UK manufacturer of Zomorph MR morphine brand was fruitless.
22 March 2021
11:4911:49, 22 March 2021diffhist+22
Metronidazole
Implying that it it may not be considered safe in breastfeeding misrepresents the consensus and cause undue worry.
16:1916:19, 6 September 2019diffhist+43
Metronidazole
Metronidazole benzoate hydrolysed in GI tract rather then stomach, and unsuitability in feeding tubes is unsupported by primary evidence and unreferenced by authors speculating it to be the case.
14:5314:53, 2 September 2019diffhist+120
Metronidazole
→Medical uses: Paper reference 13 does not provide a source for the claim that metronidazole benzoate requires hydrolysis in the stomach for efficacy and in personal communication the authors were unable to provide a source. I suspect it is long-running folk-wisdom; without evidence it should not be asserted as fact.
10:3610:36, 18 December 2018diffhist+78
Nitrofurantoin
This uncommon reaction may occur 1 month to 6 years after starting the drug and is usually related to its total lifetime dose.{{Citation needed|reason= source for lifetinme dose claim|date=December 2018}}
12 November 2018
10:3110:31, 12 November 2018diffhist−314
Aminolevulinic acid
→Activation of mitochondria: thereby increasing glucose consumption and it helps in addressing the problem of low energy levels of patients.<ref>Bratic, I., Trifunovic, A. (2010). Mitochondrial energy and ageing. Biochimica et Biophysica Acta-Bioenergetics, 1797,961-967.</ref>" deletd comment as claim is not supported by the referencece provided. "Energy levels" is a nonsense term and smacks or quackery and vested interest.
8 November 2018
17:1617:16, 8 November 2018diffhist−20
Medical cannabis
Whole-plant cannabis for medicinal use is not legal in the UK. The recent legal changes allow for cannabis-based medicinal products. See https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/753172/Factsheet_-_Cannabis_CBD_and_Cannabinoids_-_v_1_2__2018.pdf